BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9713484)

  • 1. DNA content of parathyroid tumors.
    Bocsi J; Perner F; Szücs J; Glaz E; Kopper L
    Anticancer Res; 1998; 18(4B):2901-4. PubMed ID: 9713484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of flow cytometry in the study of parathyroid hyperplasia and adenomas].
    Mangili F; Sassi I; Schiaffino E; Zogno C; Cantaboni A; Schmid C
    Pathologica; 1992; 84(1092):459-65. PubMed ID: 1491887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nuclear DNA content of parathyroid tumor with hyperparathyroidism].
    Suzuki S; Ando Y; Ami H; Furukawa H; Tsuchiya A; Abe R
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():486-91. PubMed ID: 9589058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric DNA analysis of parathyroid tumors with special reference to its diagnostic and prognostic value in parathyroid carcinoma.
    Obara T; Fujimoto Y; Hirayama A; Kanaji Y; Ito Y; Kodama T; Ogata T
    Cancer; 1990 Apr; 65(8):1789-93. PubMed ID: 1969327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis.
    Stojadinovic A; Hoos A; Nissan A; Dudas ME; Cordon-Cardo C; Shaha AR; Brennan MF; Singh B; Ghossein RA
    Hum Pathol; 2003 Jan; 34(1):54-64. PubMed ID: 12605367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric DNA analysis of normal and pathologic parathyroid glands.
    Harlow S; Roth SI; Bauer K; Marshall RB
    Mod Pathol; 1991 May; 4(3):310-5. PubMed ID: 2068056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative activity and genetic changes in adrenal cortical tumors examined by flow cytometry, fluorescence in situ hybridization and immunohistochemistry.
    Takehara K; Sakai H; Shono T; Irie J; Kanetake H
    Int J Urol; 2005 Feb; 12(2):121-7. PubMed ID: 15733104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deoxyribonucleic acid cytometry helps identify parathyroid carcinomas.
    Levin KE; Chew KL; Ljung BM; Mayall BH; Siperstein AE; Clark OH
    J Clin Endocrinol Metab; 1988 Oct; 67(4):779-84. PubMed ID: 3417849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatemia is related to chromosomal aberrations of parathyroid glands in patients with hyperparathyroidism.
    Chudek J; Nagy A; Kokot F; Podwinski A; Wiecek A; Ritz E; Kovacs G
    J Nephrol; 2007; 20(2):164-72. PubMed ID: 17514620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA content in malignant salivary gland tumours.
    Monteiro LS; Palmeira C; Bento MJ; Lopes C
    Oral Dis; 2009 May; 15(4):295-301. PubMed ID: 19320959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between clinical and histological findings in parathyroid tumors suspicious for carcinoma.
    Chang YJ; Mittal V; Remine S; Manyam H; Sabir M; Richardson T; Young S
    Am Surg; 2006 May; 72(5):419-26. PubMed ID: 16719197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region.
    Onaran Y; Tezelman S; Gürel N; Terzioğlu T; Oğuz H; Tanakol R; Kapran Y
    Acta Chir Belg; 1999 Feb; 99(1):30-5. PubMed ID: 10090961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis?
    Fernandez-Ranvier GG; Khanafshar E; Jensen K; Zarnegar R; Lee J; Kebebew E; Duh QY; Clark OH
    Cancer; 2007 Jul; 110(2):255-64. PubMed ID: 17559137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [DNA content and survival in subserous gallbladder carcinoma].
    Roa I; de Aretxabala X; Fuentealba P; Cabrera ME; Araya JC; Roa J
    Rev Med Chil; 2004 Jul; 132(7):794-800. PubMed ID: 15379325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear DNA density of parathyroid lesions.
    Howard S; Anderson C; Diels W; Gerres K; Garcia B
    Pathol Res Pract; 1992 Jun; 188(4-5):497-9. PubMed ID: 1409078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
    Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K
    J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA ploidy in soft tissue sarcoma: comparison of flow and image cytometry with clinical follow-up in 93 patients.
    Dreinhöfer KE; Baldetorp B; Akerman M; Fernö M; Rydholm A; Gustafson P
    Cytometry; 2002 Feb; 50(1):19-24. PubMed ID: 11857594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
    Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
    Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of DNA ploidy and proliferative indices in patients with nasopharyngeal carcinoma.
    Ma J; Nicholas ; Terry HA; Lin SX; Patel N; Mai HG; Hong MH; Lu TX; Cui NJ; Min HQ
    Ai Zheng; 2002 Jun; 21(6):644-50. PubMed ID: 12452067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation of the HRPT2 gene in parathyroid carcinoma.
    Hewitt KM; Sharma PK; Samowitz W; Hobbs M
    Ann Otol Rhinol Laryngol; 2007 Dec; 116(12):928-33. PubMed ID: 18217513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.